mefloquine has been researched along with Akinetic Autism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanemitsu, M; Matsumoto, M; Naito, K; Nakamura, T; Ohshita, T; Sekine, M; Ueno, H; Yamawaki, T | 1 |
| Nevin, RL | 1 |
2 other study(ies) available for mefloquine and Akinetic Autism
| Article | Year |
|---|---|
Akinetic mutism caused by HIV-associated progressive multifocal leukoencephalopathy was successfully treated with mefloquine: a serial multimodal MRI Study.
Topics: Akinetic Mutism; HIV Infections; Humans; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Mefloquine; Middle Aged; Treatment Outcome | 2012 |
Neuropharmacokinetic heterogeneity of mefloquine in the treatment of progressive multifocal leukoencephalopathy.
Topics: Akinetic Mutism; HIV Infections; Humans; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Mefloquine | 2012 |